GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

GE HealthCare Technologies Inc.

BK Medical

GE HealthCare India

Every day millions of people feel the impact of our intelligent devices, advanced analytics and artificial intelligence. As a leading global medical technology and digital solutions innovator, GE HealthCare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform.

With over 100 years of healthcare industry experience and around 50,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.

We embrace a culture of respect, transparency, integrity and diversity and we work to create a world where healthcare has no limits.

GE HealthCare

Meet Robert, one of the minds behind the creation of Portrait™ Mobile, our wireless and wearable patient monitoring device.

Keep an eye on our channels to find out how Robert, and the rest of the GE HealthCare team, set out to enhance the future of patient monitoring.

#FlexAcuityMatters #FutureofHealthcare #PatientMonitoring #HealthcareCareers #HealthcareInnovation #DayintheLife

How many of these will you tick off in 2024? ✅

Let us know if you've got any ambitions or resolutions for the new year in the comments below and be sure to keep us updated with how you get on! 

#FutureofHealthcare #Healthcare #NewYearResolutions

As 2023 draws to a close, we wanted to reflect on what an amazing year it's been! 💜

From Founders Day in January to GE HealthCare Girls Day and RSNA, we've had a blast this year! We can't wait to keep sharing inspiring clinician and patient stories from around the world in addition to exciting events and company updates throughout 2024. 🌎 

There are big things ahead, so keep your eyes peeled! 👀

#NewYear #FutureofHealthcare #GEHealthCare

The magic of the holidays is certainly being felt at our site in Buc, France! 🇫🇷 Many of our colleagues' children took part in a competition to showcase the magic of Christmas in healthcare and here are some of their creations. 🎨

Thank you to Thomas, Ninon, Nayla, Naveen, Mattéo, Cat Tuong and Agathe as well as the many others who shared their masterpieces. 

#Healthcare #Holidays #FestiveHolidays

He's making a list and checking it twice - once for gifts and once for a PET/CT scanner that helps with a healthy, holly-jolly season! 🎄 🩺

Thank you to all the healthcare professionals worldwide who are on hand day in and day out to ensure everyone is in tip-top shape for the holidays and every day after that. 

#Imaging #Holidays #FutureofHealthcare

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	1.68B -	2.06B 22.43%	2.27B 10.54%	1.95B 14.33%	1.62B 16.98%
depreciation and amortization	659M -	630M 4.40%	625M 0.79%	633M 1.28%	610M 3.63%
deferred income tax	410M -	652M 59.02%	600M 7.98%	563M 6.17%	743M 31.97%
stock based compensation	151M -	-931M 716.56%	76M 108.16%	67M 11.84%	114M 70.15%
change in working capital	-387M -	-52M 86.56%	-1.37B 2,534.62%	-256M 81.31%	-131M 48.83%
accounts receivables	-272M -	-221M 18.75%	-1.34B 504.52%	-231M 82.71%	-185M 19.91%
inventory	-173M -	100M 157.80%	-435M 535%	-402M 7.59%	111M 127.61%
accounts payables	-1M -	-113M 11,200%	263M 332.74%	481M 82.89%	-13M 102.70%
other working capital	59M -	182M 208.47%	138M 24.18%	-104M 175.36%	-44M 57.69%
other non cash items	-525M -	-670M 27.62%	-599M 10.60%	-843M 40.73%	-853M 1.19%
net cash provided by operating activities	1.99B -	1.69B 15.18%	1.61B 4.74%	2.11B 31.49%	2.10B 0.57%
investments in property plant and equipment	-331M -	-259M 21.75%	-248M 4.25%	-310M 25%	-387M 24.84%
acquisitions net	52M -	-78M 250%	-1.48B 1,798.72%	4M 100.27%	-147M 3,775%
purchases of investments
sales maturities of investments
other investing activites	-46M -	20.32B 44,280.43%	-32M 100.16%	-92M 187.50%	-24M 73.91%
net cash used for investing activites	-325M -	19.99B 6,249.54%	-1.76B 108.81%	-398M 77.40%	-558M 40.20%
debt repayment	-63M -	-20M 68.25%	-17M 15%	-3M 82.35%	-855M 28,400%
common stock issued
common stock repurchased
dividends paid					-41M -
other financing activites	-1.51B -	-21.52B 1,324.49%	-246M 98.86%	-819M 232.93%	418M 151.04%
net cash used provided by financing activities	-1.57B -	-21.54B 1,268.74%	-263M 98.78%	-822M 212.55%	-478M 41.85%
effect of forex changes on cash	-55M -	14M 125.45%	-34M 342.86%	-3M 91.18%	-10M 233.33%
net change in cash	35M -	143M 308.57%	-451M 415.38%	890M 297.34%	1.05B 18.54%
cash at beginning of period	834M -	869M 4.20%	1.01B 16.46%	561M 44.57%	1.45B 158.65%
cash at end of period	869M -	1.01B 16.46%	561M 44.57%	1.45B 158.65%	2.51B 72.71%
operating cash flow	1.99B -	1.69B 15.18%	1.61B 4.74%	2.11B 31.49%	2.10B 0.57%
capital expenditure	-331M -	-259M 21.75%	-248M 4.25%	-310M 25%	-387M 24.84%
free cash flow	1.66B -	1.43B 13.87%	1.36B 4.83%	1.80B 32.67%	1.71B 4.94%

COM:GEHEALTHCARE

GE HealthCare

Last Close

82.00

22/11 21:00

Market Cap

36.12B

Beta: -

Volume Today

5.31M

Avg: -

Preview